Skip to main content

187 publications

Name Date Type Actions

Buyback programs - April 2022

Monthly communication regarding buyback programs

 

Description of buyback programs

Availability of the 2021 Universal Registration Document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

Public releases

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

Public releases

Buyback programs - March 2022

Monthly communication regarding buyback programs

 

Description of buyback programs

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

Public releases

Buyback programs - January 2022

Description of buyback programs

Double-digit growth in 2021

Total Group Sales: €521 million (up 21.9% as reported)
Annual Sale of Essential products: €296 million (up 34.0% as reported)

Public releases

Third quarter revenues: €132 million

Public releases

2021 first half results

2021 Half year results

Public releases

Descriptif du programme de rachat d’actions propres soumis à l’assemblée générale mixte du 27 mai 2021 (french)

Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions autorisé par l’assemblée générale mixte du 27 mai 2021.

Description of buyback programs